Metabolic & Cardiometabolic
dietary fiber decreases GLP-1 resistance
In plain terms: Does fibre help your body respond better to its own appetite-suppressing hormone GLP-1?
Leans support Metabolic & Cardiometabolic 🔬 Includes disconfirming
Part of: 🧪 dietary fiber
RefutedContestedStrong support
consensus score 0.28
Probably yes as a mechanism, but only shown in the lab and cells so far, not in people.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Human trials (RCT / n-of-1)
MechanismIn-vitroAnimalObservationalRCTMeta-analysis
How the studies fall
13 support 1 contradict 2 tested null 7 mixed · 23 sources, 14 independent groups
What the evidence shows
Fiber/beta-glucan maintain tight junctions (occludin, ZO-1), lowering LPS translocation and endotoxemia, which de-represses GLP-1 signaling (GPR41/43, FXR, TGR5). Directly names a fiber already in the bakery program — a defensible 'reduce GLP-1 resistance' hypothesis, but review-grade.
The evidence (23)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Chambers 2015 · Proc Nutr Soc | mechanism | supports | moderate | Mechanistic review: fermentable-fiber SCFAs stimulate L-cell GLP-1/PYY via FFAR2/3, suppressing appetite and energy intake. |
| Rukeye A et al 2026 · study_type: animal | animal | supports | low | Wheat bran (10-15% dietary fiber) fed to high-fat-diet Sprague-Dawley rats for 12 weeks reduced hepatic/colonic oxidative stress (SOD, GSH-Px up; MDA down), ameliorated colonic mucosal histopathology, and increased serum/colonic GLP-1 vs hi |
| de Freitas Queiroz Barros HD et al 2026 · study_type: mechanism | mechanism | mixed | low | Narrative review describing how obesogenic (low-fiber-implied) diets reduce SCFA production, alter bile acids, and increase endotoxin signaling, impairing intestinal barrier function and promoting metabolic endotoxemia that reaches the brai |
| Zhang Y et al 2026 · study_type: observational | observational | supports | low | Review of T2D gut microbiome multi-omics describes reduced SCFA/secondary bile acid production and increased endotoxin-related metabolism linked to gut barrier integrity, inflammatory tone, and insulin sensitivity, but does not address GLP- |
| Chambers ES, et al. (Frost) 2015 · Gut | RCT | supports | moderate | Colonic propionate delivery raised PYY/GLP-1 secretion and reduced energy intake/weight gain in overweight adults. |
| Christiansen 2018 2018 · Am J Physiol GI | in-vitro | supports | moderate | SCFAs stimulate colonic GLP-1 secretion (ex-vivo) |
| Rahat-Rozenbloom S, et al. 2017 · Eur J Clin Nutr | RCT | contradicts | moderate | Acute inulin-driven rises in serum SCFA did not increase GLP-1 or PYY in lean/overweight humans (possible SCFA resistance). |
| Sun LY et al 2026 · study_type: mechanism | mechanism | supports | low | Narrative review on diabetic kidney disease describes fiber fermentation producing SCFAs (e.g. butyrate) with anti-inflammatory/renal-protective effects, and intestinal barrier dysfunction/metabolic endotoxemia as drivers of a systemic infl |
| Meng Y et al 2026 · study_type: animal | animal | supports | low | Oat β-glucan given to obese mice improved glucose tolerance/insulin resistance and increased GLP-1 secretion via gut-microbiota-driven secondary bile acid (FXR inhibition) and succinate-mediated intestinal gluconeogenesis pathways. |
| Hirdaramani 2026 · Communications Biology | in-vitro | mixed | low | Butyrate via FFAR2-Gai programs human L-cell identity and a PYY-biased secretory profile; amplifiable pharmacologically. |
| Mazhar 2023 · Foods | observational | supports | low | Review: dietary-fiber-derived SCFAs enhance GLP-1/PYY release via GPR41/43 and improve insulin sensitivity in T2D. |
| Yang W et al 2026 · study_type: mechanism | mechanism | mixed | low | Narrative review on gut-microbiota-GLP-1 links notes GLP-1 is secreted under gut-microbiota regulation and supports microbial homeostasis, framing GM-GLP-1 axis modulation (including fiber/microbiota-targeted strategies) as a therapeutic di |
| Nilsson 2008 · J Nutr | RCT | supports | moderate | Indigestible carbohydrate at evening meal improved next-morning glucose tolerance with higher GLP-1 and colonic fermentation. |
| Hamdan A et al 2026 · study_type: observational | mechanism | supports | low | Narrative review states diet-induced dysbiosis alters intestinal barrier integrity, promotes metabolic endotoxemia, and impairs enteroendocrine hormone secretion, with fiber enrichment cited among interventions that can partially restore mi |
| Zhang 2019 · Sci Rep | RCT | mixed | low | 40g/d RS2 crossover increased acetate, early-phase insulin/C-peptide/GLP-1 and reduced visceral fat in normal-weight subjects. |
| van der Beek 2018 2018 · Metabolism | RCT | mixed | moderate | inulin raised SCFA/substrate metabolism; GLP-1 effect modest/inconsistent |
| Ganguly NK et al 2026 · study_type: mechanism | mechanism | supports | low | Commentary on India's 'thin-fat phenotype' describes impaired dietary fiber fermentation, reduced SCFA, metabolic endotoxemia and SCFA-mediated incretin secretion as interconnected drivers of metabolic vulnerability, citing emerging RCTs of |
| Irfan 2026 · Diabetes Res Clin Pract | meta-analysis | mixed | moderate | Prebiotics raise SCFA-FFAR2/3-driven GLP secretion; human incretin effects modest/variable by fiber type, dose, baseline microbiota. |
| Deng H et al 2026 · study_type: mechanism | observational | mixed | low | Review of TCM-derived compounds in MASLD describes polysaccharides/other natural compounds repairing intestinal mucosal barrier and regulating SCFA/bile-acid metabolism via FXR/TGR5/TLR4 pathways relevant to metabolic disease, but focuses o |
| Kaji 2014 · Digestion | mechanism | supports | moderate | Review of SCFA receptor (FFAR2/GPR43) contribution to GLP-1 release from enteroendocrine L-cells. |
| Hunt 2024 · Metabolites | animal | tested-null | moderate | SCFAs induce GLP-1 via FFAR2/3 in perfused colon, but fiber-free-diet colitis severity was independent of the SCFA-FFAR2/3-GLP-1 pathway. |
| Ali et al. 2026 · Int J Biol Macromol | mechanism | supports | low | Bioactive polysaccharides (beta-glucan) -> tight-junction maintenance -> lower LPS -> support GLP-1 |
| Maziarz 2017 · Nutrition Journal | RCT | tested-null | low | HAM-RS2 improved postprandial glucose but did not significantly raise GLP-1/PYY or reduce adiposity in overweight adults. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.